Suppressive effect of elongation factor 2 on apoptosis induced by HIV-1 viral protein R

Azad AA. Could Nef and Vpr proteins contribute to disease progression by promoting depletion of bystander cells and prolonged survival of HIV-infected cells?. Biochem Biophys Res Commun 2000; 267(3): 677–685.

Bukrinsky M, Adzhubei A. Viral protein R of HIV-1. Rev Med Virol 1999; 9(1): 39–49.

Emerman M. HIV-1, Vpr and the cell cycle. Curr Biol 1996; 6(9): 1096–1103.

Ferri KF, Kroemer G. Organelle-specific initiation of cell death pathways. Nat Cell Biol 2001; 3(11): E255–E263.

Talapatra S, Thompson CB. Growth factor signaling in cell survival: implications for cancer treatment. J Pharmacol Exp Ther 2001; 298(3): 873–878.

Chen M, Wang J. Initiator caspases in apoptosis signaling pathways. Apoptosis 2002; 7(4): 313–319.

Budihardjo I, Oliver H, Lutter M, Luo X, Wang X. Biochemical pathways of caspase activation during apoptosis. Annu Rev Cell Dev Biol 1999; 15: 269–290.

Li P, Nijhawan D, Budihardjo I, et al. Cytochrome c and dATP-dependent formation of Apaf-1/caspase-9 complex initiates an apoptotic protease cascade. Cell 1997; 91(4): 479–489.

Dejean LM, Martinez-Caballero S, Guo L, et al. Oligomeric, Bax Is a Component of the Putative, Cytochrome c Release Channel, MAC, Mitochondrial, Apoptosis-induced Channel. Mol Biol Cell 2005.

Hajra KM, Liu JR. Apoptosome dysfunction in human cancer. Apoptosis 2004; 9(6): 691–704.

Higuchi M, Proske RJ, Yeh ET. Inhibition of mitochondrial respiratory chain complex I by TNF results in cytochrome c release, membrane permeability transition, and apoptosis. Oncogene 1998; 17(19): 2515–2524.

Ahlemeyer B, Klumpp S, Krieglstein J. Release of cytochrome c into the extracellular space contributes to neuronal apoptosis induced by staurosporine. Brain Res 2002; 934(2): 107–116.

Desagher S, Osen-Sand A, Nichols A, et al. Bid-induced conformational change of Bax is responsible for mitochondrial cytochrome c release during apoptosis. J Cell Biol 1999; 144(5): 891–901.

Tafani M, Cohn JA, Karpinich NO, Rothman RJ, Russo MA, Farber JL. Regulation of intracellular pH mediates Bax activation in HeLa cells treated with staurosporine or tumor necrosis factor-alpha. J Biol Chem 2002; 277(51): 49569–49576.

Zhao RY, Bukrinsky M, Elder RT. HIV-1 Viral Protein R (Vpr) and Host Cellular Responses. Ind J Med Res 2005; 121(4): 270–286.

Zhao Y, Elder RT. Yeast perspectives on HIV-1 Vpr. Frontiers in Bioscience 2000; 5: 905–916.

Macreadie IG, Thorburn DR, Kirby DM, Castelli LA, de Rozario NL, Azad AA. HIV-1 protein Vpr causes gross mitochondrial dysfunction in the yeast Saccharomyces cerevisiae. FEBS Lett 1997; 410(2–3): 145–149.

Macreadie IG, Castelli LA, Hewish DR, Kirkpatrick A, Ward AC, Azad AA. A domain of human immunodeficiency virus type 1 Vpr containing repeated H(S/F)RIG amino acid motifs causes cell growth arrest and structural defects. Proc Natl Acad Sci USA 1995; 92(7): 2770–2774.

Zhao Y, Cao J, O'Gorman MRG, Yu M, Yogev R. Effect of human immunodeficiency virus Type 1 protein R (vpr) gene expression on basic cellular functions of fission yeast Schizosaccharomyces pombe. J Virol 1996; 70: 5821–5826.

Zhao Y, Yu M, Chen M, Elder RT, Yamamoto AJC. Pleiotropic effects of HIV-1 protein R (Vpr) on morphogenesis and cell survival in fission yeast and antagonism by pentoxifylline. Virol 1998a; 246: 266–276.

Elder RT, Yu M, Chen M, Zhu X, Yanagida M, Zhao Y. HIV-1 Vpr induces cell cycle G2 arrest in fission yeast (Schizosaccharomyces pombe) through a pathway involving regulatory and catalytic subunits of PP2A and acting on both Wee1 and Cdc25. Virol 2001; 287(2): 359–370.

Maundrell K. Thiamine-repressible expression vectors pREP and pRIP for fission yeast. Gene 1993; 123(1): 127–130.

Zhao Y, Yu M, Chen M, Elder RT, Yamamoto A, Cao J. Pleiotropic effects of HIV-1 protein R (Vpr) on morphogenesis and cell survival in fission yeast and antagonism by pentoxifylline. Virol 1998; 246: 266–276.

Chen M, Elder RT, Yu M, et al. Mutational analysis of Vpr-induced G2 arrest, nuclear localization, and cell death in fission yeast. J Virol 1999; 73(4): 3236–3245.

Zhao Y, Cao J, O'Gorman MRG, Yu M, Yogev R. Effect of human immunodeficiency virus Type 1 protein R (vpr) gene expression on basic cellular functions of fission yeast Schizosaccharomyces pombe. J Virol 1996; 70: 5821–5826.

Zhao Y, Elder RT, Chen M, Cao J. Fission yeast expression vectors adapted for large scale cloning and GFP fusion with positive screening. BioTechniques 1998; 25: 438–444.

Elder RT, Yu M, Chen M, Zhu X, Yanagida M, Zhao Y. HIV-1 Vpr induces cell cycle G2 arrest in fission yeast (Schizosaccharomyces pombe) through a pathway involving regulatory and catalytic subunits of PP2A and acting on both Wee1 and Cdc25. Virology 2001; 287(2): 359–370.

Benko Z, Liang D, Agbottah E, et al. Anti-Vpr activity of a yeast chaperone protein. J Virol 2004; 78(20): 11016–11029.

Susin SA, Lorenzo HK, Zamzami N, et al. Molecular characterization of mitochondrial apoptosis-inducing factor. Nature 1999; 397(6718): 441–446.

Zhang S, Feng Y, Narayan O, Zhao L. Cytoplasmic retention of HIV-1 regulatory protein Vpr by protein-protein interaction with a novel human cytoplasmic protein VprBP. Gene 2001; 263(1–2): 131–140.

Chowdhury IH, Wang XF, Landau NR, et al. HIV-1 Vpr activates cell cycle inhibitor p21/Waf1/Cip1: a potential mechanism of G2/M cell cycle arrest. Virology 2003; 305(2): 371–377.

Amini S, Saunders M, Kelley K, Khalili K, Sawaya BE. Interplay between HIV-1 Vpr and Sp1 modulates p21(WAF1) gene expression in human astrocytes. J Biol Chem 2004; 279(44): 46046–46056.

Rebbaa A, Chou PM, Emran M, Mirkin BL. Doxorubicin-induced apoptosis in caspase-8-deficient neuroblastoma cells is mediated through direct action on mitochondria. Cancer Chemother Pharmacol 2001; 48(6): 423–428.

Javelaud D, Besancon F. Inactivation of p21WAF1 sensitizes cells to apoptosis via an increase of both p14ARF and p53 levels and an alteration of the Bax/Bcl-2 ratio. J Biol Chem 2002; 277(40): 37949–37954.

Elder RT, Benko Z, Zhao Y. HIV-1 VPR modulates cell cycle G2/M transition through an alternative cellular mechanism other than the classic mitotic checkpoints. Front Biosci 2002; 7: d349–d357.

Zhao Y, Lieberman HB. Schizosaccharomyces pombe: A model for molecular studies of eukaryotic genes. DNA Cell Biol 1995; 14(5): 359–371.

Gogal RM, Jr., Smith BJ, Kalnitsky J, Holladay SD. Analysis of apoptosis of lymphoid cells in fish exposed to immunotoxic compounds. Cytometry 2000; 39(4): 310–318.

Muthumani K, Hwang DS, Desai BM, et al. HIV-1 Vpr induces apoptosis through caspase 9 in T cells and peripheral blood mononuclear cells. J Biol Chem 2002; 277(40): 37820–37831.

Tafani M, Schneider TG, Pastorino JG, Farber JL. Cytochrome c-dependent activation of caspase-3 by tumor necrosis factor requires induction of the mitochondrial permeability transition. Am J Pathol 2000; 156(6): 2111–2121.

Rhoads RE. Signal transduction pathways that regulate eukaryotic protein synthesis. J Biol Chem 1999; 274(43): 30337–30340.

Ryazanov AG, Spirin AS. Phosphorylation of elongation factor 2: A key mechanism regulating gene expression in vertebrates. New Biol 1990; 2(10): 843–850.

Ryazanov AG. Elongation factor-2 kinase and its newly discovered relatives. FEBS Lett 2002; 514(1): 26–29.

Marin P, Nastiuk KL, Daniel N, et al. Glutamate-dependent phosphorylation of elongation factor-2 and inhibition of protein synthesis in neurons. J Neurosci 1997; 17(10): 3445–3454.

Arora S, Yang JM, Kinzy TG, et al. Identification and characterization of an inhibitor of eukaryotic elongation factor 2 kinase against human cancer cell lines. Cancer Res 2003; 63(20): 6894–6899.

Iglewski WJ. Cellular ADP-ribosylation of elongation factor 2. Mol Cell Biochem 1994; 138(1–2):131–133.

Iglewski BH, Liu PV, Kabat D. Mechanism of action of Pseudomonas aeruginosa exotoxin Aiadenosine diphosphate-ribosylation of mammalian elongation factor 2 in vitro and in vivo. Infect Immun 1977; 15(1): 138–144.

Morimoto H, Bonavida B. Diphtheria toxin- and Pseudomonas A toxin-mediated apoptosis. ADP ribosylation of elongation factor-2 is required for DNA fragmentation and cell lysis and synergy with tumor necrosis factor-alpha. J Immunol 1992; 149(6): 2089–2094.

Dorovkov MV, Pavur KS, Petrov AN, Ryazanov AG. Regulation of elongation factor-2 kinase by pH. Biochemistry 2002; 41(45): 13444–13450.

Feuermann M, Francisci S, Rinaldi T, et al. The yeast counterparts of human 'MELAS' mutations cause mitochondrial dysfunction that can be rescued by overexpression of the mitochondrial translation factor EF-Tu. EMBO Rep 2003; 4(1): 53–58.